Late-stage pipeline progress

Dr Sean Bohen, AstraZeneca’s Executive Vice-President of Global Medicines Development and the Chief Medical Officer, talks about the YTD and Q3 2015 late-stage pipeline progress across our main therapy areas: respiratory diseases, inflammation and autoimmunity; cardiovascular and metabolic disease; and oncology.

tags

  • Corporate and financial